期刊
JOURNAL OF AUTOIMMUNITY
卷 32, 期 3-4, 页码 216-222出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jaut.2009.02.015
关键词
SKG/Jcl mouse; Autoimmune disease; Bone marrow transplantation; Stem cell
类别
资金
- Ministry of Education
- Ministry of Education, Culture, Sports, Science and Technology
- Department of Transplantation for Regeneration Therapy (Sponsored by Otsuka Pharmaceutical Company, Ltd.)
- Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd.
- Japan Immunoresearch Laboratories Co., Ltd. (JIMRO)
The treatment of autoimmune diseases by allogeneic bone marrow transplantation remains a promising therapeutic avenue. However, more intensive studies on murine models are essential before application to a large number of human patients. In particular, the use of bone marrow transplantation to treat rheumatoid arthritis has been problematic. We have taken advantage of the SKG/Jcl mouse that develops a chronic T cell-mediated autoimmune disease that mimics rheumatoid arthritis which attempted to prevent the development of immunopathology in these mice by allogeneic bone marrow transplantation (BMT). In particular, we utilized our unique technology in which bone marrow cells (BMCs) of control C57BL/6J mice are directly injected into the bone marrow cavity in the tibia of SKG mice (intra-bone marrow [IBM]-BMT). As controls, SKG/Jcl mice were transplanted with whole BMCs from syngeneic SKG mice. Importantly, 12 months after IBM-BMT [B6 -> SKG] demonstrated no evidence of arthritis, whereas the control [SKG -> SKG] mice demonstrated, the expected immunopathology of a rheumatoid arthritis-like condition. Further, hematolymphoid cells in [B6 -> SKG] mice were reconstituted by donor-derived cells and the percentages of Treg (Foxp3(+)/CD4(+)) cells, the percentages of receptor activator of nuclear factor-kappa B ligand (RANKL)(+) cells on the CD44(+)T cells and the serum levels of tumor necrosis factor-cc, interleukin-1 and interleukin-6 were normalized in the [B6 -> SKG] mice. These data suggest that IBM-BMT is a viable method of immunological manipulation that suppresses the severe joint destruction and bone absorption in SKG/Jcl mice and lends further credence to the use of this methodology in humans with intractable rheumatoid arthritis. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据